Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
The Breast Journal
|
June 27, 2007
Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifen
Hyman B Muss, Janice Yanushka Bunn, Abigail Crocker, et al.
British Journal of Neurosurgery
|
April 25, 2023
<i>NF2</i> mutation associated with accelerated time to recurrence for older patients with atypical meningiomas
Jonathan T Dullea, Danielle Chaluts, Vikram Vasan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2018
Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
Chrisann Kyi, Vladimir Roudko, Rachel Sabado, et al.
Journal of Neuro-Oncology
|
November 27, 2022
NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas
Vikram Vasan, Jonathan T Dullea, Alex Devarajan, et al.
Journal of Cancer Research and Clinical Oncology
|
November 8, 2022
ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas
Danielle Chaluts, Jonathan T Dullea, Muhammad Ali, et al.
Neurosurgical Focus
|
February 1, 2022
Association of mutations in DNA polymerase epsilon with increased CD8+ cell infiltration and prolonged progression-free survival in patients with meningiomas
John W Rutland, Jonathan T Dullea, Corey M Gill, et al.
NPJ Breast Cancer
|
November 16, 2017
A metastasis biomarker (MetaSite <i>Breast</i>™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer
Joseph A Sparano, Robert Gray, Maja H Oktay, et al.
Oncoscience
|
December 14, 2022
Association between tumor mutations and meningioma recurrence in Grade I/II disease
Jonathan T Dullea, Vikram Vasan, John W Rutland, et al.
Online Journal of Public Health Informatics
|
February 18, 2017
Cross-Disciplinary Consultancy to Enhance Predictions of Asthma Exacerbation Risk in Boston
Margaret Reid, Julia Gunn, Snehal Shah, et al.
Neuro-Oncology
|
March 18, 2020
Recurrent IDH mutations in high-grade meningioma
Corey M Gill, Joshua Loewenstern, John W Rutland, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
The Breast Journal
|
June 27, 2007
Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifen
Hyman B Muss, Janice Yanushka Bunn, Abigail Crocker, et al.
British Journal of Neurosurgery
|
April 25, 2023
<i>NF2</i> mutation associated with accelerated time to recurrence for older patients with atypical meningiomas
Jonathan T Dullea, Danielle Chaluts, Vikram Vasan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2018
Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
Chrisann Kyi, Vladimir Roudko, Rachel Sabado, et al.
Journal of Neuro-Oncology
|
November 27, 2022
NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas
Vikram Vasan, Jonathan T Dullea, Alex Devarajan, et al.
Journal of Cancer Research and Clinical Oncology
|
November 8, 2022
ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas
Danielle Chaluts, Jonathan T Dullea, Muhammad Ali, et al.
Neurosurgical Focus
|
February 1, 2022
Association of mutations in DNA polymerase epsilon with increased CD8+ cell infiltration and prolonged progression-free survival in patients with meningiomas
John W Rutland, Jonathan T Dullea, Corey M Gill, et al.
NPJ Breast Cancer
|
November 16, 2017
A metastasis biomarker (MetaSite <i>Breast</i>™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer
Joseph A Sparano, Robert Gray, Maja H Oktay, et al.
Oncoscience
|
December 14, 2022
Association between tumor mutations and meningioma recurrence in Grade I/II disease
Jonathan T Dullea, Vikram Vasan, John W Rutland, et al.
Online Journal of Public Health Informatics
|
February 18, 2017
Cross-Disciplinary Consultancy to Enhance Predictions of Asthma Exacerbation Risk in Boston
Margaret Reid, Julia Gunn, Snehal Shah, et al.
Neuro-Oncology
|
March 18, 2020
Recurrent IDH mutations in high-grade meningioma
Corey M Gill, Joshua Loewenstern, John W Rutland, et al.
Page
of 7